XTRA:BAYNPharmaceuticals
Bayer Reshapes Pharma And Crop Science With Perfuse Deal And bp Alliance
Bayer has agreed to acquire Perfuse Therapeutics, its largest drug deal in years, to expand its ophthalmology portfolio.
The company announced a new alliance with bp to develop and commercialize camelina as a feedstock for sustainable fuels.
Phase III REVEAL study results for Bayer's cardiac imaging agent in diagnostics were reported as positive.
Bayer (XTRA:BAYN), trading around €38.51, is trying to reshape both its pharmaceuticals and crop science businesses after a mixed share price...